Sphingosine is an endogenous biomolecule significantly increased in patients with Gaucher disease (GD) due to the Glucocerebrosidase (GCase) deficiency in this disease (Mistry et al., 2014). This evidence concerns the gene GBA1 and Gaucher disease.